Business / Finance RSS Feed - Business / Finance

EarlySense completes $20 million financing round

EarlySense completes $20 million financing round

EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber. [More]
Gecko Biomedical obtains 1.3 million euros to advance Bio-inspired Surgical Solutions

Gecko Biomedical obtains 1.3 million euros to advance Bio-inspired Surgical Solutions

Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces today it has received 1.3 million euros from Bpifrance to advance its Bio-inspired Surgical Solutions. [More]
Solvanix set up to commercialise novel antibody-stabilisation technology

Solvanix set up to commercialise novel antibody-stabilisation technology

The Garvan Institute of Medical Research announces the launch of spin-off company Solvanix Pty Ltd, set up to commercialise a novel technology that will improve the stability of therapeutic monoclonal antibodies. [More]

GI Partners acquires Logibec from OMERS Private Equity

GI Partners, a leading middle market private equity firm, announced today that it has completed the previously announced acquisition of Logibec, Inc., a Canadian healthcare IT company, from OMERS Private Equity. [More]
Signostics gets FDA 510k clearance for handheld bladder scanner

Signostics gets FDA 510k clearance for handheld bladder scanner

Medical device company, Signostics, announced today it has clearance from the U.S. Food and Drug Administration to launch the SignosRT Bladder, the company’s new hand-held bladder scanner. [More]
EKF highlighting heat and humidity compatible POC hemoglobin analyzer at Arab Health 2015

EKF highlighting heat and humidity compatible POC hemoglobin analyzer at Arab Health 2015

EKF Diagnostics, the global diagnostics company, announces that it will be highlighting the robustness of its new DiaSpect Tm point of care (POC) hemoglobin analyzer at Arab Health 2015, 26-29th January, Dubai, UAE. Also on Stand Z1G30, EKF will be discussing its new liquid-stable assay* for early sepsis detection, as well as previewing SensPoint, a new hand-held lactate analyzer with built-in connectivity functions to hospital or laboratory information systems. [More]
Philips, Indica Labs partner to offer advanced image analysis algorithms for cancer research

Philips, Indica Labs partner to offer advanced image analysis algorithms for cancer research

Royal Philips today announced that it will further support oncology researchers' efforts to analyze pathology samples by offering advanced image analysis algorithms from Indica Labs, Inc. as part of its Digital Pathology Solutions offerings. [More]

CTI Life Sciences announces closing of second venture capital fund

CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan. [More]

Vygon strengthens Asia-Pacific presence with new subsidiary in Singapore

Vygon, the specialist single-use medical devices group, today announces the opening of a subsidiary in Singapore. [More]
3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody ("mAb") targeting both VEGFR2/KDR and Tie-2 pathways for cancer in the territory of Greater China (including mainland China, Taiwan, Hong Kong and Macau) and Korea. [More]
Major investment boosts Scotland's gene research

Major investment boosts Scotland's gene research

A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare. [More]
Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Intrexon Corporation, a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology, today announced a broad exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sublicensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies. [More]
EvoNexus announces graduation of TruMed Systems

EvoNexus announces graduation of TruMed Systems

EvoNexus a San Diego-based incubator for technology startup companies, today announces the graduation of TruMed Systems, creators of the turnkey Vaccine Management Solution AccuVax. [More]
Beckman Coulter Genomics announces CAP accreditation

Beckman Coulter Genomics announces CAP accreditation

Beckman Coulter Genomics, a leading provider of DNA Sequencing Services announces today accreditation from the College of American Pathologists (CAP). [More]
Digital healthcare communications: an interview with David Hunt, CEO of HAVAS LYNX Europe

Digital healthcare communications: an interview with David Hunt, CEO of HAVAS LYNX Europe

Digital has excited the industry, it has hinted at a brighter future, a potential competitive advantage and most importantly a better purpose, however like many others, it has not been the revolution it might have been. [More]
BioLight invests in newly-formed ophthalmic company

BioLight invests in newly-formed ophthalmic company

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced its investment in a newly-formed ophthalmic company that has licensed-in a world-wide drug-delivery platform from the Hebrew University, Israel, that has the potential to enable more efficient and safer delivery of eye drops. [More]
MGB Biopharma provides update on business performance for 2014

MGB Biopharma provides update on business performance for 2014

MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, provides an update on its business performance for 2014. MGB Biopharma is developing a pipeline of novel antimicrobials that puts it at the forefront of addressing the major global problem of antimicrobial resistance. [More]
Biogen Idec, Columbia University Medical Center form $30 million genomics research alliance

Biogen Idec, Columbia University Medical Center form $30 million genomics research alliance

Biogen Idec and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches. As part of this agreement, a sequencing and analysis facility and shared postdoctoral program will be established at Columbia to support collaborative genetics studies. [More]
Advisory Board announces completion of Royall acquisition

Advisory Board announces completion of Royall acquisition

The Advisory Board Company, a global insight-driven technology, research, and services provider, today announced the completion of its acquisition of Royall & Company. [More]
Memorial Prompt Care & Family Medicine becomes MemorialCare Medical Group

Memorial Prompt Care & Family Medicine becomes MemorialCare Medical Group

Memorial Prompt Care & Family Medicine announced that it has changed its name to MemorialCare Medical Group. Affiliated with the nationally recognized MemorialCare Health System, it was a natural fit for them to become part of the award-winning MemorialCare Medical Group. The name change is effective immediately. [More]